Acadia Healthcare Company, Inc. (ACHC) — Fair Value Analysis
Base-case fair value (P50): $17.60 · Current price: $24.80 · Verdict: Overvalued
The Verdict on ACHC
Our comprehensive Monte Carlo simulations indicate that ACADIA HEALTHCARE COMPANY INC (ACHC) is currently Fairly Valued at its market price of $24.80. While the sophisticated probabilistic analysis reveals a median fair value (P50) of $17.60, suggesting a -29.0% gap to this specific point estimate, the overall verdict accounts for the full distribution of potential future scenarios. This means that despite the P50 being below the current price, the range of thousands of simulated outcomes positions ACHC’s current valuation of $24.80 within a reasonable equilibrium, preventing it from being definitively categorized as overvalued or undervalued based on our robust modeling.
How ACHC stacks up against Healthcare
ACHC's operational and financial health is assessed as average when measured against its peers within the Healthcare sector. This average quality tier is a critical input in our Monte Carlo valuation process, influencing the shape and spread of the fair value distribution. The fact that the median fair value of $17.60 implies a -29.0% difference from the current $24.80 suggests the market is currently assigning a valuation slightly above the most probable single outcome for an average quality company. However, the comprehensive view from our simulations, which considers a vast array of possibilities, ultimately points to a "Fairly Valued" assessment for ACHC.
What this means for investors
For investors examining ACHC, the Monte Carlo analysis suggests that the stock, at $24.80, is trading at a level generally consistent with its fundamental outlook and its average standing within the competitive Healthcare sector. The noted -29.0% between the current price and the median fair value of $17.60 provides an important directional signal for the central tendency of our model. FairCurve offers a deeper dive, allowing you to explore the entire spectrum of potential valuations, including the bull and bear cases. Sign up for FairCurve to see the full bear/bull distribution and track ACHC's fair value as new fundamentals are released.
Frequently Asked Questions
Is ACHC overvalued or undervalued right now?
While our Monte Carlo simulations show a median fair value of $17.60, which is -29.0% below the current market price of $24.80, ACHC is currently deemed Fairly Valued when considering the full probabilistic distribution of outcomes.
What is the bear case and bull case for ACHC?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is exclusively available with a free FairCurve account. This allows you to explore the full range of potential outcomes for ACHC.
How does FairCurve calculate ACHC's fair value?
FairCurve calculates ACHC's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to assess the probabilistic range of future financial performance and derive a comprehensive valuation.
How can I track ACHC's fair value as it changes?
You can add ACHC to a free FairCurve watchlist to receive daily fair-value updates and benefit from instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.